TR200003544T2 - Kas-iskelet zayıflığının tedavisine yönelik terapötik kombinasyonlar. - Google Patents

Kas-iskelet zayıflığının tedavisine yönelik terapötik kombinasyonlar.

Info

Publication number
TR200003544T2
TR200003544T2 TR2000/03544T TR200003544T TR200003544T2 TR 200003544 T2 TR200003544 T2 TR 200003544T2 TR 2000/03544 T TR2000/03544 T TR 2000/03544T TR 200003544 T TR200003544 T TR 200003544T TR 200003544 T2 TR200003544 T2 TR 200003544T2
Authority
TR
Turkey
Prior art keywords
compositions
treatment
therapeutic combinations
oxo
breakdown
Prior art date
Application number
TR2000/03544T
Other languages
English (en)
Turkish (tr)
Inventor
Zhu Ke Hua
Li Mei
Codetta Pan Lydia
Duane Thompson David
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR200003544T2 publication Critical patent/TR200003544T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
TR2000/03544T 1998-06-16 1999-06-16 Kas-iskelet zayıflığının tedavisine yönelik terapötik kombinasyonlar. TR200003544T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
TR200003544T2 true TR200003544T2 (tr) 2001-04-20

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03544T TR200003544T2 (tr) 1998-06-16 1999-06-16 Kas-iskelet zayıflığının tedavisine yönelik terapötik kombinasyonlar.

Country Status (30)

Country Link
EP (1) EP1087764A1 (xx)
JP (1) JP2002518326A (xx)
KR (1) KR20010052852A (xx)
CN (1) CN1301160A (xx)
AP (1) AP9901582A0 (xx)
AR (1) AR018869A1 (xx)
AU (1) AU4054799A (xx)
BG (1) BG105041A (xx)
BR (1) BR9911324A (xx)
CA (1) CA2335134A1 (xx)
CO (1) CO5070587A1 (xx)
EA (1) EA200001186A1 (xx)
GT (1) GT199900087A (xx)
HN (1) HN1999000097A (xx)
HR (1) HRP20000859A2 (xx)
HU (1) HUP0102505A3 (xx)
ID (1) ID27599A (xx)
IL (1) IL138630A0 (xx)
IS (1) IS5691A (xx)
MA (1) MA26652A1 (xx)
NO (1) NO20006312D0 (xx)
OA (1) OA11505A (xx)
PA (1) PA8475901A1 (xx)
PE (1) PE20000646A1 (xx)
PL (1) PL344981A1 (xx)
SK (1) SK18912000A3 (xx)
TN (1) TNSN99124A1 (xx)
TR (1) TR200003544T2 (xx)
WO (1) WO1999065486A1 (xx)
ZA (1) ZA993975B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2360103A1 (en) * 1999-02-08 2000-08-17 Robert Sladek Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha
DE60124616T2 (de) 2000-05-08 2007-09-13 Pfizer Products Inc., Groton Enzymatische Spaltung von selektiven Modulatoren des Östrogenrezeptors
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
CA2420535A1 (en) * 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
EP2118080B1 (en) 2007-02-09 2016-08-31 Ocera Therapeutics, Inc. Macrocyclic ghrelin receptor modulators and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
HUP0102505A3 (en) 2002-12-28
AR018869A1 (es) 2001-12-12
PE20000646A1 (es) 2000-08-05
AP9901582A0 (en) 1999-06-30
PA8475901A1 (es) 2000-05-24
ID27599A (id) 2001-04-12
KR20010052852A (ko) 2001-06-25
WO1999065486A1 (en) 1999-12-23
OA11505A (en) 2004-05-07
BG105041A (en) 2001-08-31
AU4054799A (en) 2000-01-05
SK18912000A3 (sk) 2001-10-08
IS5691A (is) 2000-10-27
MA26652A1 (fr) 2004-12-20
HUP0102505A2 (hu) 2001-11-28
IL138630A0 (en) 2001-10-31
BR9911324A (pt) 2001-04-03
NO20006312L (no) 2000-12-12
HN1999000097A (es) 1999-11-03
PL344981A1 (en) 2001-11-19
CA2335134A1 (en) 1999-12-23
NO20006312D0 (no) 2000-12-12
CN1301160A (zh) 2001-06-27
EP1087764A1 (en) 2001-04-04
JP2002518326A (ja) 2002-06-25
HRP20000859A2 (en) 2001-04-30
TNSN99124A1 (fr) 2005-11-10
CO5070587A1 (es) 2001-08-28
ZA993975B (en) 2000-12-15
EA200001186A1 (ru) 2001-06-25
GT199900087A (es) 2000-12-07

Similar Documents

Publication Publication Date Title
DE60037836D1 (de) ThiazoloÄ4,5-dÜpyrimidinverbindungen zur Behandlung von rheumathoider Arthritis
LU91710I2 (fr) Pazopanib, facultativement sous forme d'un sel ou d'un solvate pharmaceutiquement acceptable de celui-ci
CY1108874T1 (el) ΧΡΗΣΗ ΤΩΝ ΑΝΑΣΤΟΛΕΩΝ Ι κΒ- ΚΙΝΑΣΗΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΠΟΝΟΥ
TR199802273T2 (xx) Fibrotik lezyonlar�n onar�lmas� ve �nlenmesi.
IL165262A (en) Kinase inhibitors and pharmaceutical compositions containing them
DK0657458T3 (da) Inhibitorer af proteinkinase-C
HUP0500173A2 (hu) Alfa-szulfonamido-acetamid-származékok mint béta-amiloid inhibitorok és a vegyületeket tartalmazó gyógyszerkészítmények
MY131911A (en) N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran or dihydrobenzodioxin) carboxamide derivatives
IL165264A (en) Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases
SI1509232T1 (sl) Kombinacija antagonista nmda in zaviralcev acetilholinesteraze za zdravljenje alzheimerjeve bolezni
DK0969832T3 (da) Farmaceutisk sammensætning til oral administration af et N-piperidino-3-pyrazolcarboxamidderivat, dets salte og deres solvater
GB0223040D0 (en) Therapeutic compounds
SV2003000633A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7
ATE332903T1 (de) Kondensierte pyridoindolderivate
IL94278A0 (en) 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
TR200003544T2 (tr) Kas-iskelet zayıflığının tedavisine yönelik terapötik kombinasyonlar.
UA66872C2 (uk) Сполука, яка є памоатом оланзапіну або його сольватом, та спосіб лікування психотичних розладів
NZ330944A (en) Peptide derivatives
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
BR9813719A (pt) Agentes terapêuticos
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
AP9901581A0 (en) Therapeutic combinations for musculoskeletal frailty.
BR0111102A (pt) Uso de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorofenil)etil]-4pip eridinometanol ou sua pró-droga no tratamento de sintomas de demência e psicose induzida por dopamina
MXPA05014143A (es) Derivados de cumarina para el tratamiento de trastornos oftalmicos.
MY134059A (en) Novel use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts